Medicus Pharma (MDCX) Stock Price, Quote, News & History | Benzinga

Medicus Pharma Ltd (MDCX) Stock Price, Quote, News & History

MDCXNASDAQ

Trade with Public

Trade with Public

$0.2801

-0.0739-20.88%

At close: Aug 14, 5:00 PM EST

$0.2800

-0.0001-0.04%

After Hours: Aug 14, 7:59 PM EST

Earnings: Q2 2026 Earnings were released on Wed Aug 12th, after the market close

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$0.35

Close

$0.28

Volume / Avg.

2.77M / 1.95M

Day Range

$0.28 - $0.36

52 Wk Range

0.25 - 3.05

Market Cap

$15.86M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

41

Short Interest

5.6%

Days to Cover

1.8

Recent Medicus Pharma Ltd News

EXCLUSIVE: Medicus Pharma Launches Genomics-Guided Endometriosis Study In Abu Dhabi

Medicus Pharma obtained UAE approval for its PRECISION-E2 Phase 2a clinical trial testing Teverelix in endometriosis patients.

Vandana Singh

Medicus Pharma To Highlight SkinJect Phase 2 Data And Teverelix Clinical Advances At BIO 2026

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutic

Benzinga News-desk

EXCLUSIVE: Medicus Sees Strongest Efficacy At Higher Dose In Skin Cancer Study

Medicus Pharma reports dose-response in Phase 2 BCC study, with 200µg cohort showing the strongest efficacy and safety profile at Day 57.

Vandana Singh

Why Organon Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Organon & Co (OGN) jumped 14.8% in pre-market trading as Sun Pharma agreed to acquire the company for $11.75 billion, $2 higher than current price.

Avi Kapoor

Why J B Hunt Transport Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

J B Hunt Transport Services Inc (JBHT) stock rose in pre-market trading after beating earnings estimates. Gainers include CTNT, MYSE, WNW, MDCX, WSHP, MAMO, ALIT, HQ, and SLDP while XHG and BIRD were among the losers.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-27.81M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

35.01M

Free Cash Flow (TTM)

-27.81M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

2.58M

Analyst Trends and Forecast

2

Mar

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$12.04M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

15.21

Earnings Yield % (TTM)

-738.76%

Earnings Yield % (FWD)

-160.01%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.02

Company Debt

Total Debt

$2.36M

LT Debt

$21.04K

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$10.58M

Total Cash

$6.37M

Debt to Equity

1.91

Issuance of Debt (TTM)

$1.29M

Repayment of Debt (TTM)

-$10.58M

Key Statistics

Open

$0.35

Close

$0.28

Volume / Avg.

2.77M / 1.95M

Day Range

$0.28 - $0.36

52 Wk Range

0.25 - 3.05

Market Cap

$15.86M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

41

Short Interest

5.6%

Days to Cover

1.8

About

Sector

Health Care

Industry

Biotechnology

Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Medicus Pharma (MDCX) stock?

A

You can purchase shares of Medicus Pharma (NASDAQ:MDCX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Medicus Pharma (MDCX) competitors?

A

Other companies in Medicus Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Medicus Pharma (MDCX) stock?

A

Medicus Pharma has a consensus price target of $14.50.

Q

What is the current price for Medicus Pharma (MDCX)?

A

The stock price for Medicus Pharma (NASDAQ: MDCX) is $0.28 last updated August 14, 2026 at 7:59 PM EDT.

Q

Does Medicus Pharma (MDCX) pay a dividend?

A

There are no upcoming dividends for Medicus Pharma.

Q

When is Medicus Pharma (NASDAQ:MDCX) reporting earnings?

A

Medicus Pharma does not have any upcoming earnings scheduled.

Q

Is Medicus Pharma (MDCX) going to split?

A

There is no upcoming split for Medicus Pharma.

Q

What sector and industry does Medicus Pharma (MDCX) operate in?

A

Medicus Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.